Join
Live feed
·
PRReleasevia Quantisnow
Annovis Bio Inc. logo

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

ByQuantisnow·Wall Street's wire, on your screen.
ANVS· Annovis Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANVS (Annovis Bio Inc.) and more on Quantisnow.